Loading...

Surrozen, Inc.

SRZNW•NASDAQ
Healthcare
Biotechnology
$0.03
$0.007(35.64%)
U.S. Market opens in 6h 22m

Surrozen, Inc. (SRZNW) Stock Overview

Explore Surrozen, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap190.7K
P/E Ratio-1.03
EPS (TTM)$-5.70
ROE6.11%
Fundamental Analysis

AI Price Forecasts

1 Month$0.02
3 Months$0.02
1 Year Target$0.00

SRZNW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Surrozen, Inc. (SRZNW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 60.61, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.03 and a market capitalization of 190.7K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
35.64%
5-Day Change
50.00%
1-Month Change
50.00%
3-Month Change
-7.10%
6-Month Change
372.22%
Year-to-Date (YTD) Change
27.50%
1-Year Change
10.87%
3-Year Change
-71.67%
5-Year Change
-97.52%
All-Time (Max) Change
-98.62%

Contact Information

http://www.surrozen.com
650 489 9000
171 Oyster Point Boulevard, South San Francisco, CA, 94080

Company Facts

400 Employees
IPO DateAug 10, 2021
CountryUS
Actively Trading

Frequently Asked Questions